World's Best Scientists 2026 revealed!
Nicolas Girard

Nicolas Girard

D-Index & Metrics

Medicine

D-Index
79
Citations
22869
World Ranking
17564
National Ranking
583

Overview

Nicolas Girard is affiliated with the Institute Curie in France, contributing extensively to the field of medical research with a significant focus on pulmonary and respiratory medicine as well as oncology. Their scholarly output encompasses research that intersects neurology, radiology, nuclear medicine and imaging, and epidemiology, reflecting a broad engagement with medical sciences.

Their published works primarily revolve around lung cancer treatments and mutations, lung cancer diagnosis and treatment, and lung cancer research studies. Additional topics of research include cancer immunotherapy and biomarkers, myasthenia gravis and thymoma, colorectal cancer treatments and studies, and cancer genomics and diagnostics.

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Myasthenia Gravis and Thymoma
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics

Among the frequent co-authors working with Girard are Benjamin Besse, Enriqueta Felip, C. Chouaïd, M. Pérol, and Éric Pichon, indicating substantial collaborative efforts within their research community.

  • Benjamin Besse
  • Enriqueta Felip
  • C. Chouaïd
  • M. Pérol
  • Éric Pichon

The venues for Girard's publications include key peer-reviewed journals in oncology and respiratory medicine. These comprise the Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer, and Revue des Maladies Respiratoires Actualités, reflecting a consistent presence in specialized scientific literature.

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Annals of Oncology
  • Lung Cancer
  • Revue des Maladies Respiratoires Actualités

Representative recent publications illustrate the focus on lung cancer and targeted therapies:

  • Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study (2021, Journal of Clinical Oncology)
  • Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study (2023, Annals of Oncology)
  • Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus (2020, Annals of Oncology)
  • Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions (2023, New England Journal of Medicine)
  • Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC (2024, New England Journal of Medicine)

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • New driver mutations in non-small-cell lung cancer

    William Pao;Nicolas Girard

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes

    Alexander Marx;John K.C. Chan;Jean-Michel Coindre;Frank Detterbeck

  • Amivantamab in EGFR exon 20 insertion-mutated non-small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study

    Keunchil Park;Eric B Haura;Natasha B Leighl;Paul L R Mitchell

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Deep learning-based classification of mesothelioma improves prediction of patient outcome.

    Pierre Courtiol;Charles Maussion;Matahi Moarii;Elodie Pronier

  • Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    N Girard;E Ruffini;A Marx;Corinne Faivre-Finn

  • Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

    Myriam Delaunay;Jacques Cadranel;Amélie Lusque;Nicolas Meyer

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • The Integrated Genomic Landscape of Thymic Epithelial Tumors

    Milan Radovich;Curtis R. Pickering;Ina Felau;Gavin Ha

  • Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review

    Florence Huguet;Nicolas Girard;Clotilde Séblain-El Guerche;Christophe Hennequin

  • SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.

    Francois Le Loarer;Francois Le Loarer;Sarah Watson;Gaelle Pierron;Vincent Thomas de Montpreville

  • ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting

    Alexander Marx;Philipp Ströbel;Philipp Ströbel;Sunil S. Badve;Lara Chalabreysse

  • Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.

    Nicolas Girard;Charuhas Deshpande;Christopher Lau;David Finley

  • Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies—mature results of the French Phase II RTF-1 trial

    Françoise Mornex;Nicolas Girard;Christophe Beziat;Abdul Kubas

Frequent Co-Authors

Benjamin Besse
Benjamin Besse University of Paris-Saclay
Julien Mazieres
Julien Mazieres Paul Sabatier University
Sylvie Lantuejoul
Sylvie Lantuejoul Grenoble Alpes University
Jacques Cadranel
Jacques Cadranel Université Paris Cité
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Jean-François Cordier
Jean-François Cordier Claude Bernard University Lyon 1
Pascal Thomas
Pascal Thomas Aix-Marseille University
William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean you have to pursue the traditional MD route. There are several online healthcare degrees designed for different backgrounds, career goals, and schedules. For working professionals wanting to move into healthcare management, finding whats the best online mha program for working adults can help advance their careers with flexible learning options.

Nurses seeking to enhance their qualifications may be interested in RN to BSN programs that don't require additional clinical work. By researching rn to bsn no clinical hours, registered nurses can find programs that fit around their existing commitments and avoid duplicating clinical experience.

For those aiming for the highest level of nursing practice, options like the fastest online dnp programs are available, allowing for quicker advancement. Additionally, community discussions on the easiest dnp program reddit can offer insights from current students about the most manageable and supportive online DNP pathways.

Online programs in healthcare are continually evolving, offering diverse paths to further your education and career—no matter your starting point.

Best Scientists Citing Nicolas Girard

Trending Scientists